Clinical Trial Update: PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for PSMA-directed para-aortic radiation therapy in oligorecurrent prostate cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Miami | Conditions: Prostate Cancer, Prostate Adenocarcinoma | Phase 2 | Status: RECRUITING